In contrast, a recent analysis from the German-Austrian AML Study Group in over 3,300 R/R patients treated on several prospective salvage regimens also did not identify the presence of a FLT3-ITD mutation as predictive of response to salvage therapy although patients harboring this mutation did experience worse overall survival [2]. Here, FLT3 is linked to acute myeloid leukemia.